Held on Thursday 26 and Friday 27 October 2017 at Sydney Showground, Sydney Olympic Park, this unique stat​ewide gathering showcased local innovation that has made a difference to patient care across New South Wales. Around 1000 clinicians, consumers, academics, Board members and managers from health services, non-government and professional organisations came together to share expertise, celebrate achievement and look towards the future.

http://www.health.nsw.gov.au/innovation/2017symposium/Pages/default.aspx

MTPConnect released a report in June 2017 providing an overview of the entire clinical trials scene in Australia. It highlights significant contribution that clinical trials makes to the Australian economy and provides an evaluation on Australia's strong competitive position in the world market. 

 

Click on the image to download the report.

 

The ClinTrial Refer SHP App was successfully launched on the 18th of October 2017 at the annual SHP forum.

The Sydney Health Partners ClinTrial app is the first to include trials from a range of different disciplines - including cardiology, neurology, gastroenterology, psychiatry - rather than being specific to one type of cancer.

We would like to thank all members of the Haematology Clinical Research Network. “This project has been instrumental in increasing enrolment to clinical trials- a great breakthrough. It is our patients that are benefitting. Being referred to a hospital for a clinical trial is a team effort.” Roslyn Ristuccia

http://www.prnewswire.com/news-releases/bonnie-j-addario-lung-cancer-foundation-awards-180000-clinical-trial-innovation-prize-300459893.html
Second Place: The other winners are Judith Trotman and Roslyn Ristuccia of Australia who developed the app ClinTrial Refer, which increases the cross-referral of patients between hospitals by enhancing doctors' knowledge of current trials. The use of this app has increased trial recruitment by more than 50 percent. ClinTrial Refer enhances communication among oncologists, trial units and potential patients. "The ClinTrial Refer app allows networks of trial units to collaborate and contribute current listings about recruiting trials. The app is free to download and be-comes the clinician's best resource," Trotman said. "The main barrier to improving recruitment is doctors knowing where and how to refer patients. Now they can look up current information within seconds, during a consultation visit. Patients can gather the knowledge they need for decisions on all available treatment options at www.clintrial.org.au."

Wednesday, 1 November, we had the privilege to be invited to be a panellist on a discussion about patient engagement in clinical trials at the Medical Technology Association of Australia’s (MTAA) annual medtech industry conferenceMedTech 2017. 

Visit https://research4.me/medtech2017-patient-involvement-in-clinical-trials/ for the full article.

(Panellists (L to R): Janelle, Tanya, Lillian, Roslyn, Melanie, and Tina)

The survey results are in, we would like to thank all those that participated. We hope to make this a regular exercise to help steer ClinTrial Refer in the right direction.

LINK

 

 

Congratulations go to Orange Clinical Trials Centre in Central West New South Wales on being selected to receive the 2017 Award. https://gicancer.org.au/news/agitg-outstanding-site-award/ 

Dr Teresa Anderson's Sydney Health Partner presentation at the 2016 NHMRC Symposium on Research Translation. ClinTrial Refer slide at 8:35.

Link

 

 

The announcement today of $750,000 in funding for the ClinTrial Refer Australia app project will boost the recruitment of patients to clinical trials Australia-wide.

This funding will allow ClinTrial Refer Australia to develop a new IT platform to integrate derivative apps; create one combined database; enable electronic referrals; link to Australian New Zealand Clinical Trials Registry (ANZCTR); and build a national solution to clinical trials recruitment.  

MTP Connect* – the Medical Technologies and Pharmaceuticals Industry Growth Centre – has announced $375,000 funding for the project over two years, with matched provisional funding of $375,000 coming from the sector.

In this radio interview, hear Dr Hilda High speaking to Steve Price on 2GB about The Cancer Genetics Fund and hereditary cancer research.

http://www.2gb.com/audioplayer/206546

 

Dr Hilda High works hard to provide equity of access to cancer genetics services and cancer research trials wherever people live in Australia. Listen to Julie McCrossin interview Hilda, https://www.cancercouncil.com.au/podcasts/episode-9-genetic-tests-and-cancer/ 

 

A Cooperative Group Committed To Lymphoma Research

The Lymphoma Study Association (LYSA) launches the ClinTrial Refer Lysa App

ClinTrial Refer is very excited to announce the launch of the LYSA app in France.

On the Mornings with Wendy Harmer, Dr Norman Swan explains the basics of clinical trials. “Survival is higher when you are on a clinical trial.” Skip to 6:50 if you would like to listen to how ClinTrial Refer helps to connect patients to trials.

http://www.abc.net.au/radio/sydney/programs/mornings/the-waiting-room:-drug-trials/8830362

 

The Australian Breakthrough Cancer (ABC) Study needs your help to investigate the causes of cancer and other diseases by completing an online questionnaire and providing a saliva sample (via post).

You can get involved if you're:

  • An Australian resident
  • Aged 40 to 74 years
  • Have never been diagnosed with cancer

 

In 2016 the Clinical Trials Stream was awarded a $40,000 grant from Sydney Health Partners to accelerate the development of the Sydney Health Partners ClinTrial Refer app. 

https://www.slhd.nsw.gov.au/sydneyhealthpartners/SHP-referApp.html

COSA is pleased to release the national implementation guide for the Australasian Tele-trial Model

Roslyn Ristuccia at the Sydney Innovation and Research Symposium 2017 highlighting published results on the effectiveness of ClinTrial Refer apps.

 

https://youtu.be/cYBOLseAd2w

Research Essentials has been a collaborative process involving some 60 contributors across science, research

 

WhiMSICAL is a global clinical trial inviting Waldenstrom's Macroglobulinemia (WM) patients to provide their clinical data which will help advance current knowledge and understanding of this disease. CART-WHEEL (Center for Analysis of Rare Tumors) is a database designed to address some of the barriers facing effective research into rare cancers. Show your support and spread the word. If you are a WM patient or know of one, send them to www.cart-wheel.org and complete a simple survey. 

Linking patients with researchers regardless of postcode

The Cancer Genetics Fund launches the ClinTrial Refer Cancer Genetics App

The majority of eligible rural and regional Australians are not involved in research. Dr Hilda High, Genetic Oncologist, explained: “I do a lot of Telehealth to rural and regional areas of Australia. Many of patients and families are very keen to be involved in research.